Protective mechanisms of polyphenol-enriched fraction of Vaccinium uliginosum L. Against blue light-induced cell death of human retinal pigmented epithelial cells

被引:16
作者
Jin, Hong Lan [1 ]
Choung, Se-Young [2 ]
Jeong, Kwang Won [1 ]
机构
[1] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, 191 Hambakmoero, Incheon 21936, South Korea
[2] Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci Pharm, Dept Prevent Pharm & Toxicol, Seoul 130701, South Korea
关键词
Vaccinium uliginosum L; A2E; Blue light; Age-related macular degeneration; ARPE-19; MACULAR DEGENERATION; INDUCED DAMAGE; A2E; LIPOFUSCIN; EXPRESSION; FLUORESCENCE; ACTIVATION; ZEAXANTHIN; APOPTOSIS; EXTRACT;
D O I
10.1016/j.jff.2017.10.009
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Accumulation of N-retinylidene-N-retinylethanolamine (A2E) in retinal pigment epithelial cells is implicated in the pathogenesis of age-related macular degeneration (AMD). A recent study has demonstrated that the polyphenol-enriched fraction of Vaccinium uliginosum L. (FH) reduces retinal damage induced by blue light in a mouse model. However, the underlying mechanism of its protective effect remains unclear. Here, we revealed that blue light irradiation of A2E-laden ARPE-19 cells can alter the transcription of genes belonging to TNF alpha signaling, UV response, complement, p53, and apoptosis pathways. FH treatment of ARPE-19 cells inhibited blue light-induced transcriptional activity of NF-kB and AP1 and activation of C3 complement. Additionally, FH protected ARPE-19 cells from blue light-induced apoptosis. Finally, we showed that FH inhibits the intracellular accumulation of A2E and induces the removal of A2E from retinal pigment cells. Taken together, our study revealed the protective mechanisms of FH against blue light-induced damage of A2E-laden RPE cells. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 42 条
[1]   Lack of Correlation Between the Spatial Distribution of A2E and Lipofuscin Fluorescence in the Human Retinal Pigment Epithelium [J].
Ablonczy, Zsolt ;
Higbee, Daniel ;
Anderson, David M. ;
Dahrouj, Mohammad ;
Grey, Angus C. ;
Gutierrez, Danielle ;
Koutalos, Yiannis ;
Schey, Kevin L. ;
Hanneken, Anne ;
Crouch, Rosalie K. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (08) :5535-5542
[2]   Human Retinal Pigment Epithelium Cells as Functional Models for the RPE In Vivo [J].
Ablonczy, Zsolt ;
Dahrouj, Mohammad ;
Tang, Peter H. ;
Liu, Yueying ;
Sambamurti, Kumar ;
Marmorstein, Alan D. ;
Crosson, Craig E. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (12) :8614-8620
[3]   Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival [J].
Alge, CS ;
Hauck, SM ;
Priglinger, SG ;
Kampik, A ;
Ueffing, M .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (04) :862-878
[4]   Age-related maculopathy: pathogenetic features and new treatment modalities [J].
Algvere, PV ;
Seregard, S .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (02) :136-143
[5]   Studying melanin and lipofuscin in RPE cell culture models [J].
Boulton, Michael E. .
EXPERIMENTAL EYE RESEARCH, 2014, 126 :61-67
[6]  
Brauns SC, 2005, ANTICANCER RES, V25, P4197
[7]  
Cai H, 2006, MOL VIS, V12, P1
[8]   PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration [J].
Chaitanya, Ganta Vijay ;
Steven, Alexander J. ;
Babu, Phanithi Prakash .
CELL COMMUNICATION AND SIGNALING, 2010, 8
[9]   Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial [J].
Chew, Emily Y. ;
Clemons, Traci E. ;
SanGiovanni, John Paul ;
Danis, Ronald ;
Ferris, Frederick L., III ;
Elman, Michael ;
Antoszyk, Andrew ;
Ruby, Alan ;
Orth, David ;
Bressler, Susan ;
Fish, Gary ;
Hubbard, Baker ;
Klein, Michael ;
Chandra, Suresh ;
Blodi, Barbara ;
Domalpally, Amitha ;
Friberg, Thomas ;
Wong, Wai ;
Rosenfeld, Philip ;
Agron, Elvira ;
Toth, Cynthia ;
Bernstein, Paul ;
Sperduto, Robert .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (19) :2005-2015
[10]  
DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955